It is reported that higher ROS levels decrease maturation by affecting the COC, and also decreases embryo development and blastocyst fragmentation [75]
To put that in perspective, medical experts generally consider a medication safe for breastfeeding if the baby receives less than 10% of the mothers dose through milk
Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Boehringer Ingelheim International GmbH, Amgen Inc., AstraZeneca PLC, Roche Holding AG, Zealand Pharma A/S, Hanmi Pharmaceutical Co., Ltd., Structure Therapeutics Inc., Altimmune, Inc., United Laboratories International Holdings Limited, Entera Bio Ltd., OPKO Health, Inc., Viking Therapeutics, Inc., Twist Bioscience Corporation and others GLP-1 agonists market is segmented based on Product, Indication , Route of Administration, Distribution Channel and Region
Allergic reactions are rare but possible with any supplement
Must comply with USP standards for sterility, potency, and purity